|
|
|
Insider
Information: |
Schuler Jack W |
Relationship: |
|
City: |
Lake Forest |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
27,956,178 |
|
Indirect Shares
|
61,134,751 |
|
|
Direct
Value |
$201,782,322 |
|
|
Indirect Value
|
$171,213,609 |
|
|
Total
Shares |
89,090,929 |
|
|
Total
Value |
$372,995,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
54
|
96
|
Stock
price went up :
|
14
|
2
|
Stock
price went down : |
40
|
94
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.7%
|
-5,816.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 16 of 26
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
QDEL |
QuidelOrtho Corporation |
Director |
|
2013-12-20 |
4 |
D |
$27.54 |
$1,038,616 |
D/D |
(37,713) |
3,354,207 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2009-11-06 |
4 |
B |
$3.90 |
$610,100 |
D/D |
154,000 |
3,354,890 |
2.45 |
- |
|
QDEL |
QuidelOrtho Corporation |
officerTitle |
|
2006-02-03 |
4 |
A |
$0.01 |
$16 |
D/D |
1,638 |
3,364,452 |
|
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2017-12-21 |
4 |
S |
$46.00 |
$23,000 |
D/D |
(500) |
3,365,053 |
0 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2017-12-20 |
4 |
S |
$44.40 |
$155,400 |
D/D |
(3,500) |
3,365,553 |
0 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2017-12-12 |
4 |
D |
$40.01 |
$653,043 |
D/D |
(16,322) |
3,369,053 |
0 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2017-12-12 |
4 |
OE |
$15.74 |
$653,024 |
D/D |
31,164 |
3,385,375 |
0 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2013-12-20 |
4 |
OE |
$9.93 |
$1,038,595 |
D/D |
76,867 |
3,391,920 |
0 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2018-01-22 |
4 |
S |
$48.50 |
$582,031 |
I/I |
(12,000) |
3,414,053 |
0 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2018-01-05 |
4 |
S |
$47.02 |
$188,080 |
I/I |
(4,000) |
3,426,053 |
0 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2006-02-03 |
4/A |
A |
$0.01 |
$16 |
D/D |
1,638 |
3,429,452 |
|
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2009-11-09 |
4 |
B |
$3.60 |
$626,615 |
D/D |
151,782 |
3,506,672 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2009-11-13 |
4 |
B |
$10.00 |
$250,000 |
D/D |
25,000 |
3,531,672 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-03-04 |
4 |
B |
$3.66 |
$146,260 |
D/D |
40,000 |
3,571,672 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-03-05 |
4 |
B |
$3.71 |
$122,791 |
D/D |
33,100 |
3,604,772 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-03-08 |
4 |
B |
$3.80 |
$60,754 |
D/D |
16,000 |
3,620,772 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-04-06 |
4 |
S |
$3.40 |
$288,575 |
D/D |
(85,000) |
3,633,779 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-03-09 |
4 |
B |
$3.77 |
$100,984 |
D/D |
26,789 |
3,647,561 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-05-07 |
4 |
B |
$3.12 |
$45,230 |
D/D |
14,515 |
3,648,294 |
2.37 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-03-10 |
4 |
B |
$3.75 |
$149,952 |
D/D |
40,000 |
3,687,561 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-03-11 |
4 |
B |
$3.64 |
$46,289 |
D/D |
12,700 |
3,700,261 |
2.37 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-03-12 |
4 |
B |
$3.74 |
$69,293 |
D/D |
18,518 |
3,718,779 |
2.45 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-05-25 |
4 |
B |
$1.94 |
$299,807 |
D/D |
126,215 |
3,774,509 |
2.45 |
- |
|
YTEN |
Yield10 Bioscience Inc |
10% Owner |
|
2019-03-14 |
4 |
B |
$1.21 |
$668,492 |
I/I |
552,427 |
3,822,908 |
1.5 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-10-09 |
4 |
B |
$0.95 |
$1,045,000 |
I/I |
1,100,000 |
3,884,666 |
1.5 |
- |
|
634 Records found
|
|
Page 16 of 26 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|